Latest in Research & Development

Eli Lilly's retatrutide achieves 28% weight loss in Phase III trial

The Zepbound and Foundayo manufacturer saw significant weight loss results on par with those from bariatric surgery, as well as improvements in cardiometabolic health measures

Find out more

Concept Life Science and OpenBench team up on AI-driven hit discovery platform for biotechs

The pair will combine AI-powered virtual screening, medicinal chemistry and in-vitro validation in a fee-for-success model designed to accelerate hit identification and reduce...
See more

etherna's mRNA and LNP platforms advance Dropshot Therapeutics' renal disease programme to clinical stage

etherna has announced that partner Dropshot Therapeutics has validated its platforms in preclinical renal disease research and will now progress to IND-enabling studies, with etherna providing GMP manufacturing support ahead of planned Phase I clinical trials in 2027

VoxCell BioInnovation and adMare partner to validate bioprinted vascularised cancer tissue models for antibody therapy development

The pair have announced a research collaboration using VoxCell's human-relevant bioprinted vascularised cancer tissue models to validate a novel antibody-based immune-modulating therapy, as the FDA advances plans to reduce animal testing for monoclonal antibodies through New Approach Methodologies

Brainomix and Boehringer Ingelheim continue partnership in pulmonary fibrosis

The pair will advance their strategic partnership to the next phase of clinical trials for Brainomix's e-Lung after strong initial results demonstrated its potential to enable earlier diagnosis of progressive pulmonary fibrosis

Johnson & Johnson to present new portfolio and pipline data at APA and ASCP

The firm will showcase data across its neuropsychiatry portfolio at the APA and ASCP annual meetings, including long-term CAPLYTA relapse prevention data in schizophrenia and Phase III seltorexant analyses in major depressive disorder with insomnia symptoms

Fujifilm develops cyclic peptide screening platform for challenging membrane protein targets

The compa has created a novel mRNA display screening methodology capable of identifying high-affinity cyclic peptides against multi-pass transmembrane proteins on living cell surfaces, overcoming a key limitation of conventional approaches that require protein isolation and risk disrupting native structures

Bristol Myers Squibb licenses Lonza ADC linker-payload technology for undisclosed target

BMS has secured exclusive access to Lonza’s SYNtecan linker-payload platform, alongside GlycoConnect and HydraSpace technologies, to advance development of an antibody-drug conjugate against an undisclosed target

Neuland Laboratories to partner with LIR Life Sciences for transdermal GLP-1 development

The pair will work to advance LIR Life's novel cell-penetrating peptides for next-generation obesity therapies, looking to improve patient adherence and broaden access

From lab to launch: transforming pharmaceutical formulation development with GEA’s CFC Lab Coater

A new generation of continuous film coating technology is giving R&D teams the speed, precision and scalability they need to take products from the laboratory to commercial production without the traditional bottlenecks

Latest posts in Research & Development

Hongene to support SiranBio siRNA candidate programme with CDMO services

The RNA specialist will support SiranBio's SA1211 programme, helping advance the siRNA candidate through its vertically integrated CDMO services to address the complex nature of the next-gen therapeutic

BioDuro and CTI Technology partner to push forward preclinical drug development

The duo will combine their manufacturing experience and analytical capabilities to build an integrated platform spanning all the way from drug discovery to IND submission to accelerate the drug development path for clients

Scientists develop new technique to fight antimicrobial resistance

The team of researchers from the University of Leicester have developed a new technique to sequence phage genomes from individual plaques and hopes to use it to build fully characterised libraries of bacteriophages, expanding the number of candidates available to tackle drug-resistant infections

Lancet Oncology Commission launches to examine future of academic cancer clinical trials amid funding and regulatory pressures

A global coalition of clinical investigators and patient representatives has launched the Lancet Oncology Commission to address the value and challenges of independent academic cancer clinical trials, amid growing concerns over regulatory complexity, limited public funding and the need for new international collaboration models
You need to be a subscriber to read this article.
Click here to find out more.

UK clinical trial reforms come into force in largest regulatory overhaul in 20 years

The MHRA and Health Research Authority are implementing the most significant package of clinical trial regulatory reforms in more than two decades, introducing faster assessment routes for lower-risk trials and mandatory registration of trial results

Epitopea receives MHRA approval for first-in-human trial of RNA vaccine for ovarian cancer

The company has received regulatory approval from the MHRA and Regional Ethics Committee to initiate its OVACT Phase I/Ib clinical trial of CryptiVax-1001, an off-the-shelf mRNA immunotherapy targeting high-grade serous ovarian cancer

NEUVIOR Pharmaceuticals receives Innovate UK grant to explore bio-based materials for circular pharmaceutical manufacturing

The Innovate UK feasibility grant will advance its ZYLON programme, which involves clean-chemistry lab trials exploring how bio-derived materials could replace harder-to-recycle packaging formats and reduce waste in pharmaceutical manufacturing

Awen Oncology secures seven-figure funding to advance rare bone cancer therapeutic programme

The cancer therapeutics company has secured seven-figure funding led by biotech investor Dr Urs Spitz to progress its lead programme targeting a rare form of bone cancer with potential broader oncology applications towards clinical development

Leinco Technologies and CellCarta partner to advance proteomics solutions for discovery and drug development

The pair have announced a strategic collaboration combining Leinco's IHC and spatial biology-validated antibody portfolio with CellCarta's CPTAC-validated Immuno-MRM assay resources to enhance proteomic analysis for immuno-oncology and targeted therapy development

Biognosys collaborates with Michael J. Fox Foundation to develop biomarker assays for Parkinson's research

The pair will work to develop highly sensitive, quantitative biomarker assays targeting LRRK2, the most common genetic risk factor for late-onset Parkinson's disease, in support of the foundation's global LITE initiative spanning more than 50 academic, industry and clinical partners

AstraZeneca's tozorakimab succeeds in third pivotal Phase III COPD trial

The positive results have shown that tozorakimab significantly reduced moderate-to-severe COPD exacerbations, adding to the earlier positive results from the OBERON and TITANIA trials and further supporting its potential as a first-in-class IL-33-targeting biologic

Sponsor content

Replacing discontinued OEM degasser modules

Biotech Fluidics introduces direct replacement OEM degasser modules based on upgraded vacuum technology to support continued fluidic instrument supply without costly...

CARBOGEN AMCIS introduces SPRINT for early-phase development

A new, phase-appropriate approach designed to accelerate early-phase progression while maintaining scientific rigour

Lonza expands AAV offering with Xcite AAV stable Producer Cell Line platform to idustrialise Viral Vector Manufacturing

New technology demonstrates superior performance versus transient transfection in clinically relevant customer gene of interest and engineered capsid, enabling scalable...

Piramal Pharma Solutions unveils state-of-the-art payload-linker suite at its Riverview, Michigan facility

The Riverview facility provides comprehensive services for active pharmaceutical ingredients (APIs) and high potency APIs (HPAPIs), including specialised solutions for...

Adragos Pharma appoints Kostas Rengis as Chief Executive Officer

Munich, Germany – May 7th, 2026 – Adragos Pharma, a global contract development and manufacturing organisation (CDMO), today announced the appointment of Konstantinos...

Syngene strengthens leadership team with two key appointments to support next phase of growth

Abhijit Zutshi joins as CCO and Maninder Kapoor Puri as CHRO. India/U.S./UK, 1 May 2026: Syngene International, a global contract research, development, and manufacturing...

From lab to launch: transforming pharmaceutical formulation development with GEA’s CFC Lab Coater

A new generation of continuous film coating technology is giving R&D teams the speed, precision and scalability they need to take products from the laboratory to...

Precision meets innovation in melting point determination

Advancing analytical accuracy with automated thermal analysis

Ion chromatography in pharmaceutical analysis: a long road to acceptance

John Welch, Associate Director, Butterworth Laboratories, writes on how ion chromatography evolved into a mature and widely adopted pharmaceutical analysis technique

Implementing compendial methods to minimise testing risk

Understanding feasibility testing and verification to ensure reliable analytical results

Visit Butterworth Laboratories at making pharmaceuticals 2026

Meet the team to discuss analytical testing and development support

Why patient voices matter in rare disease innovation

Patient advocacy event highlights the role of collaboration and lived experience in advancing rare disease treatments

Featured companies

Since 1974, Butterworth Laboratories has provided independent, contract analytical chemistry services to the global pharmaceutical and related industries. Consequently, we are... At Biotech Fluidics, our aim is to help you make your analytical work more effective and reliable. CARBOGEN AMCIS is a global Contract Development and Manufacturing Organization (CDMO) providing drug development and commercialization services to the pharmaceutical and... Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO), offering end-to-end development and manufacturing solutions across the drug life...
See more